LYN基因新发功能获得性变异与早发性系统性自身炎症性疾病相关
本研究旨在鉴定一种严重系统性自身炎症性疾病(SAID)的分子基础并明确其表型特征,同时对LYN基因(编码一种非受体酪氨酸激酶)所发现的序列变异进行功能评估。研究采用靶向下一代测序及体外功能研究,发现一名自出生起即反复发热、慢性荨麻疹、特应性皮炎、关节痛、炎症生物标志物升高及血浆细胞因子水平升高的患者携带新发LYN变异(p.Tyr508His),该变异与已报道的p.Tyr508Phe和p.Tyr508*变异均阻止508位残基磷酸化并导致Tyr397自磷酸化,且均激活NF-κB通路,显示涉及Tyr508的变异对Lyn活性具有功能获得性效应。
要点
- 在无SAID家族史的早发性严重系统性炎症新生儿中鉴定出LYN基因新发变异p.Tyr508His。
- p.Tyr508His、p.Tyr508Phe和p.Tyr508*三种LYN变异均阻止Tyr508磷酸化并导致Tyr397自磷酸化。
- 三种LYN变异均激活NF-κB通路,显示涉及Tyr508的变异对Lyn活性具有功能获得性效应。
核心结论
- 本研究证明了在SAID患者中鉴定的首3个LYN变异具有致病性,并描绘了一种以严重早发性系统性炎症性疾病为特征的疾病实体的表型谱,该病影响无SAID家族史的新生儿。
- 所有3个LYN变异均影响位于Lyn C末端的同一酪氨酸残基,从而证明该残基在人类Lyn活性适当调节中的关键作用。
研究设计与样本
- 采用靶向下一代测序鉴定序列变异。
- 对携带不同序列变异的重组Lyn同工型表达后的Lyn磷酸化状态及Lyn依赖性NF-κB活性进行体外功能研究。
主要发现
- 在一名自出生起即表现为反复发热、慢性荨麻疹、特应性皮炎、关节痛、炎症生物标志物升高及血浆细胞因子水平升高的患者中鉴定出新发LYN变异p.Tyr508His。
- p.Tyr508His变异及迄今报道的2个LYN变异(p.Tyr508Phe和p.Tyr508*)均阻止508位残基磷酸化并导致Tyr397自磷酸化。
- 这3个LYN变异均激活NF-κB通路,显示涉及Tyr508的变异对Lyn活性具有功能获得性效应。
关键数值与推荐
- 患者携带新发LYN变异p.Tyr508His,自出生起表现为反复发热、慢性荨麻疹、特应性皮炎、关节痛、炎症生物标志物升高及血浆细胞因子水平升高。
- p.Tyr508His、p.Tyr508Phe和p.Tyr508*三种LYN变异均阻止508位残基磷酸化并导致Tyr397自磷酸化,且均激活NF-κB通路。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To identify the molecular basis of a severe systemic autoinflammatory disorder (SAID) and define its main phenotypic features, and to functionally assess the sequence variations identified in LYN, a gene encoding a nonreceptor tyrosine kinase. METHODS: We used targeted next-generation sequencing and in vitro functional studies of Lyn phosphorylation state and Lyn-dependent NF-κB activity after expression of recombinant Lyn isoforms carrying different sequence variations. RESULTS: We identified a de novo LYN variation (p.Tyr508His) in a patient presenting since birth with recurrent fever, chronic urticaria, atopic dermatitis, arthralgia, increased inflammatory biomarkers, and elevated plasma cytokine levels. We studied the consequences on Lyn phosphorylation state of the p.Tyr508His variation and of the 2 LYN variations reported so far (p.Tyr508Phe and p.Tyr508*), and found that all 3 variations prevent phosphorylation of residue 508 and lead to autophosphorylation of Tyr397. Additionally, these 3 LYN variations activate the NF-κB pathway. These results show a gain-of-function effect of the variations involving Tyr508 on Lyn activity. CONCLUSION: This study demonstrates the pathogenicity of the first 3 LYN variations identified in SAID patients and delineates the phenotypic spectrum of a disease entity characterized by severe, early-onset, systemic inflammatory disease affecting neonates with no family history of SAID. All 3 LYN variations affect the same tyrosine residue located in the C-terminus of Lyn, thereby demonstrating the critical role of this residue in the proper regulation of Lyn activity in humans.
引用
- Louvrier C, El Khouri E, Grall Lerosey M, et al. De Novo Gain-Of-Function Variations in LYN Associated With an Early-Onset Systemic Autoinflammatory Disorder. Arthritis Rheumatol. 2022. PMID: 36122175. doi:10.1002/art.42354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。